HIGHLIGHTS
- who: Prostate Cancer (CRPC and colleagues from the University of Kansas Medical Center, United States have published the article: Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide, in the Journal: (JOURNAL) of 31/Oct/2021
- what: The authors investigated the efficacy, including prolongation of time until enzalutamide discontinuation, of the pharmacist-urologist collaborative management for outpatients with CRPC receiving enzalutamide. The aims of the collaborative management were to assist urologists in prescribing appropriate medication to patients, managing AEs and drug-drug interactions, ensuring better adherence to therapy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.